SCHEMBL5887151

SCHEMBL5887151

Cc1nc(N2CCN(C(=O)Cc3ccccc3)CC2)nc2c1ccc(=O)n2-c1ccc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.39
ALDH1A1 P00352 6/20 0.39
MAPK8 P45983 3/20 0.38
EPHX2 P34913 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
RORC P51449 1/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
HPGD P15428 1/20 0.38
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.37
RECQL P46063 1/20 0.37
GAA P10253 3/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TP53 P04637 1/20 0.37
PKM P14618 1/20 0.37
MEN1 O00255 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5886979 0.93 GBA1 (0.44) GBA1ALDH1A1HSD17B10HPGDKDM4E
SCHEMBL5886829 0.91 RAB9A (0.44) ALDH1A1MAPK8EPHX2NR1H4RORC
SCHEMBL5886790 0.91 OPRM1 (0.43) ALDH1A1MAPK8EPHX2NR1H4RORC
SCHEMBL5887039 0.91 EPHX2 (0.41) ALDH1A1MAPK8EPHX2NR1H4RORC
SCHEMBL5886702 0.90 ALDH1A1 (0.43) ALDH1A1MAPK8EPHX2NR1H4RORC
SCHEMBL5887019 0.90 ALDH1A1 (0.41) GBA1ALDH1A1MAPK8HSD17B10HPGD
SCHEMBL5886816 0.90 EPHX2 (0.41) ALDH1A1MAPK8EPHX2NR1H4RORC
SCHEMBL5887532 0.90 CA1 (0.42) ALDH1A1MAPK8EPHX2NR1H4RORC
SCHEMBL5886912 0.89 ME2 (0.43) GBA1ALDH1A1EPHX2HSD17B10HPGD
SCHEMBL5887027 0.88 KMT2A (0.45) ALDH1A1MAPK8EPHX2NR1H4RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US claimed
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors PHARMACIA ITALIA S.P.A. 2004-01-15 US claimed
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors TERT, TERF2, TERF2IP GBA1 4528/4885ALDH1A1 1860/4885MAPK8 770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.